Sotera Health (NYSE:SHC – Get Rating) had its target price lowered by The Goldman Sachs Group from $9.00 to $8.00 in a report published on Wednesday morning, Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the stock.
A number of other equities analysts have also recently issued reports on the stock. TheStreet cut shares of Sotera Health from a c- rating to a d rating in a research report on Monday, September 19th. Royal Bank of Canada cut their price objective on shares of Sotera Health from $25.00 to $8.00 and set an outperform rating on the stock in a research report on Thursday, November 3rd. Barclays cut shares of Sotera Health from an equal weight rating to an underweight rating and cut their price objective for the stock from $7.00 to $6.00 in a research report on Tuesday, November 15th. JPMorgan Chase & Co. cut their price objective on shares of Sotera Health from $9.00 to $6.00 and set an underweight rating on the stock in a research report on Thursday, November 3rd. Finally, Citigroup cut shares of Sotera Health from a buy rating to a neutral rating and cut their price objective for the stock from $25.00 to $9.00 in a research report on Wednesday, October 5th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $15.89.
Sotera Health Stock Performance
Shares of Sotera Health stock opened at $8.25 on Wednesday. The company has a market cap of $2.33 billion, a P/E ratio of 18.75 and a beta of 1.27. The business has a 50-day moving average price of $7.46 and a two-hundred day moving average price of $15.19. The company has a current ratio of 3.00, a quick ratio of 2.74 and a debt-to-equity ratio of 2.97. Sotera Health has a 1-year low of $5.78 and a 1-year high of $24.90.
Hedge Funds Weigh In On Sotera Health
Sotera Health Company Profile
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
- Get a free copy of the StockNews.com research report on Sotera Health (SHC)
- Institutional Support for Analog Devices Remains High
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Three CBD Stocks to Dominate a Budding Industry
- Microsoft Shares: Is it Time to Back Up the Truck?
- Is the 60/40 Portfolio Mix Still in Vogue?
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.